1. Home
  2. FGBI vs CGEN Comparison

FGBI vs CGEN Comparison

Compare FGBI & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGBI
  • CGEN
  • Stock Information
  • Founded
  • FGBI 1934
  • CGEN 1993
  • Country
  • FGBI United States
  • CGEN Israel
  • Employees
  • FGBI N/A
  • CGEN N/A
  • Industry
  • FGBI Savings Institutions
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FGBI Finance
  • CGEN Health Care
  • Exchange
  • FGBI Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • FGBI 122.8M
  • CGEN 125.3M
  • IPO Year
  • FGBI N/A
  • CGEN 2000
  • Fundamental
  • Price
  • FGBI $7.98
  • CGEN $1.81
  • Analyst Decision
  • FGBI
  • CGEN
  • Analyst Count
  • FGBI 0
  • CGEN 0
  • Target Price
  • FGBI N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • FGBI 12.4K
  • CGEN 644.7K
  • Earning Date
  • FGBI 10-27-2025
  • CGEN 11-11-2025
  • Dividend Yield
  • FGBI 0.50%
  • CGEN N/A
  • EPS Growth
  • FGBI N/A
  • CGEN N/A
  • EPS
  • FGBI N/A
  • CGEN N/A
  • Revenue
  • FGBI $59,070,000.00
  • CGEN $22,144,000.00
  • Revenue This Year
  • FGBI N/A
  • CGEN N/A
  • Revenue Next Year
  • FGBI $0.20
  • CGEN $208.08
  • P/E Ratio
  • FGBI N/A
  • CGEN N/A
  • Revenue Growth
  • FGBI N/A
  • CGEN N/A
  • 52 Week Low
  • FGBI $6.56
  • CGEN $1.13
  • 52 Week High
  • FGBI $15.25
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • FGBI 43.33
  • CGEN 52.46
  • Support Level
  • FGBI $7.88
  • CGEN $1.63
  • Resistance Level
  • FGBI $8.23
  • CGEN $2.38
  • Average True Range (ATR)
  • FGBI 0.28
  • CGEN 0.17
  • MACD
  • FGBI -0.08
  • CGEN -0.04
  • Stochastic Oscillator
  • FGBI 12.67
  • CGEN 20.67

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: